Picard Medical, Inc. (PMI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Picard Medical, Inc. (PMI) has a cash flow conversion efficiency ratio of -1.155x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.38 Million) by net assets ($3.79 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Picard Medical, Inc. worth for the company's overall valuation and market capitalisation.
Picard Medical, Inc. - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how Picard Medical, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Picard Medical, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Picard Medical, Inc. ranked by their cash flow conversion efficiency. See Picard Medical, Inc. cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Minbos Resources Ltd
AU:MNB
|
-0.118x |
|
Toleranzia AB
ST:TOL
|
-0.023x |
|
Asia Seed Co.Ltd
KQ:154030
|
-0.017x |
|
Agat Ejendomme A/S
CO:AGAT
|
0.005x |
|
Bionano Genomics Inc
NASDAQ:BNGO
|
-0.148x |
|
Wahana Pronatural
JK:WAPO
|
0.002x |
|
Schulte-Schlagbaum AG
DU:SSS
|
N/A |
|
Soditech SA
PA:SEC
|
0.053x |
Annual Cash Flow Conversion Efficiency for Picard Medical, Inc. (2022–2025)
The table below shows the annual cash flow conversion efficiency of Picard Medical, Inc. from 2022 to 2025. View PMI live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.79 Million | $-15.67 Million | -4.136x | -926.87% |
| 2024-12-31 | $-23.74 Million | $-11.87 Million | 0.500x | -83.29% |
| 2023-12-31 | $-3.55 Million | $-10.63 Million | 2.994x | +417.42% |
| 2022-12-31 | $11.37 Million | $-10.72 Million | -0.943x | -- |
About Picard Medical, Inc.
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internatio… Read more